Skip to content

Recombinant forms of HIV emerging rapidly, vaccine designs must keep pace

Swedish prime-boost HIV DNA vaccine shows strong responses

Adenovirus-based HIV vaccines producing strong immune responses

Panacos finds oral fusion inhibitors, provides development update on bevirimat

Draft BHIVA treatment guidelines: respond by Monday September 4th

Many HIV-positive patients in London risking their health by use of alternative therapies

Bacterial vaginosis and illness during pregnancy increase risk of in utero HIV transmission

Protease inhibitor could be used as gel to treat HPV

Final results confirm twice-daily boosted fosamprenavir is comparable to twice-daily Kaletra in treatment-naive